ICU sedation, delirium & recovery

Frailty and health‐related life quality in long‐term follow up of intensive care patients above 65 years old: Protocol for a Norwegian prospective, observational multicenter study

Acta Anaesthesiol ScandPublished Protocol for a prospective observational cohort study

Authors' conclusion

The study will assess the feasibility and measurement properties of the Clinical Frailty Scale and EQ-5D-5L in ICU survivors by telephone at long-term follow-up study and will give additional information on the frailty and HRQoL of intensive care survivors.

Study context

Population
Patients aged ≥65 years requiring invasive mechanical ventilation for ≥24 h in five Norwegian ICUsplanned 350 patients
Outcome
Frailty (Clinical Frailty Scale) and health-related quality of life (HRQoL) (EQ-5D-5L) before ICU admission compared with outcomes at follow-up
Follow-up
3 and 12 months
Methodological detailsmulticentre, ongoing, Clinical Frailty Scale and EQ-5D-5L administered at baseline (before critical illness) and at 3 and 12 months post-inclusion, EQ-5D-5L to be compared with Norwegian population norms and assessed for measurement properties
  • Multicentre
  • Ongoing
  • Clinical Frailty Scale and EQ-5D-5L administered at baseline (before critical illness) and at 3 and 12 months post-inclusion
  • EQ-5D-5L to be compared with Norwegian population norms and assessed for measurement properties

Main finding

As reported in the abstract

  • Protocol; no results reported. Inclusion started July 2022; completion planned 2025

Observational data: associations, not effects.

Original publication

Frailty and health‐related life quality in long‐term follow up of intensive care patients above 65 years old: Protocol for a Norwegian prospective, observational multicenter study. Acta Anaesthesiol Scand. Published 1 October 2024. doi:10.1111/aas.14532

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.